Rexahn Pharmaceuticals, Inc.
(NYSE Amex Equities : RNN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.46%171.321.3%$493.00m
BIIBBiogen Inc.
-0.95%226.941.3%$459.65m
CELGCelgene Corporation
-0.26%95.391.3%$443.34m
GILDGilead Sciences, Inc.
-0.39%66.910.9%$426.63m
ILMNIllumina, Inc.
1.21%312.723.5%$308.88m
REGNRegeneron Pharmaceuticals, Inc.
-0.81%312.712.6%$291.19m
AAgilent Technologies, Inc.
1.06%68.421.6%$211.85m
VRTXVertex Pharmaceuticals Incorporated
-0.69%171.821.9%$178.64m
EXASExact Sciences Corporation
3.11%96.9225.3%$168.09m
ALXNAlexion Pharmaceuticals, Inc.
1.52%127.242.0%$149.89m
BMRNBioMarin Pharmaceutical Inc.
2.28%88.964.3%$118.72m
INCYIncyte Corporation
1.68%81.852.5%$108.76m
SRPTSarepta Therapeutics, Inc.
2.16%120.8014.7%$106.90m
ALNYAlnylam Pharmaceuticals, Inc
1.50%68.939.2%$96.91m
IONSIonis Pharmaceuticals, Inc.
-3.63%64.718.2%$93.65m

Company Profile

Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD.